Research paper
Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.
About this item
- Title
- Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.
- Content partner
- Directory of Open Access Journals
- Collection
- Directory of Open Access Journals
- Description
BACKGROUND: Artemisinin combination therapies (ACTs) with broad efficacy are needed where multiple Plasmodium species are transmitted, especially in children, who bear the brunt of infection in endemic areas. In Papua New Guinea (PNG), artemether-lumefantrine is the first-line treatment for uncomplicated malaria, but it has limited efficacy against P. vivax. Artemisinin-naphthoquine should have greater activity in vivax malaria because the elimination of naphthoquine is slower than that of lu...
- Format
- Research paper
- Date created
- 2014-12-01
- Creator
- Moses Laman / Brioni R Moore / John M Benjamin / Gumul Yadi / Cathy Bona / Jonathan Warrel / Johanna H Kattenberg / Tamarah Koleala / Laurens Manning / Bernadine Kasian / Leanne J Robinson / Naomi Sambale / Lina Lorry / Stephan Karl / Wendy A Davis / Anna Rosanas-Urgell / Ivo Mueller / Peter M Siba / Inoni Betuela / Timothy M E Davis
- Contributing partner
- PLoS Medicine
- URL
- http://europepmc.org/articles/PMC4280121?pdf=render
- Related subjects
- Medicine
What can I do with this item?
Check copyright status and what you can do with this item
Check informationReport this item
If you believe this item breaches our terms of use please report this item
Report this itemDigitalNZ brings together more than 30 million items from institutions so that they are easy to find and use. This information is the best information we could find on this item. This item was added on 19 June 2016, and updated 19 July 2018.
Learn more about how we work.
Share
What is the copyright status of this item?

Share, Modify, Use commercially
See below for specifics about how you may use this item.

More Information
Directory of Open Access Journals has this to say about the rights status of this item:
CC BY (All metadata for this Directory of Open Access Journals record is available under the Creative Commons Attribution-ShareAlike License (CC BY-SA).)
You can learn more about the rights status of this item at: http://journals.plos.org/plosmedicine/s/content-license
What can I do with this item?
You must always check with Directory of Open Access Journals to confirm the specific terms of use, but this is our understanding:

Non-infringing use
NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

Share it
This item is suitable for copying and sharing with others, without further permission.

Modify it
This item is suitable for modifying, remixing and building upon, without further permission.

Use it commercially
This item is suitable for commercial use, without further permission.
What can I do with this item?
Check copyright status and what you can do with this item
Check informationReport this item
If you believe this item breaches our terms of use please report this item
Report this itemDigitalNZ brings together more than 30 million items from institutions so that they are easy to find and use. This information is the best information we could find on this item. This item was added on 19 June 2016, and updated 19 July 2018.
Learn more about how we work.
Share
Related items
Loading...